Two Sigma Securities, LLC Aeterna Zentaris Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.17 - $0.37 $6,799 - $14,798	39,997 New	39,997 $8,000
Q2 2021 Aug 16, 2021	SELL	$0.83 - $1.14 $20,410 - $28,033	-24,591 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.51 - $3.34 $12,541 - $82,133	24,591 New	24,591 $28,000
Q2 2020 Aug 14, 2020	SELL	$0.45 - $1.2 $4,931 - $13,149	-10,958 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.42 - $1.44 $4,602 - $15,779	10,958 New	10,958 $6,000
Q1 2018 May 15, 2018	SELL	$1.46 - $2.41 $23,830 - $39,336	-16,322 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$1.87 - $2.7 $19,247 - $27,791	-10,293 Reduced 38.67%	16,322 $39,000
Q3 2017 Nov 14, 2017	BUY	$1.81 - $2.23 $48,173 - $59,351	26,615	26,615 $54,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.